3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33200796 | Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer. | 2021 Jan | 2 |
| 2 | 33376097 | Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903). | 2021 Mar 15 | 1 |
| 3 | 32577785 | Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the acquired resistance of AZD9291 in H1975 cells. | 2020 Sep | 4 |